ARCHIVES

Two Groups Take Different Approaches To Managing Toxicity Of Saltz Regimen.

This article is from The Cancer Letter archive.

Vol. 27 No. 25 | June 22, 2001

Download PDF Visit The Full Archive

Related Articles

Timothy Talbot, Fox Chase Founder, Centers Advocate, Dies At Age 72

November 11, 1988

Watson Steps Down As Chancellor at Cold Spring Harbor Laboratory.

October 26, 2007

AACR 2001 Honorary Awards Announced; Nora Janjan Is ASTRO President-Elect.

January 5, 2001

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

Letter to the Editors: Loss Of ET2 Would Be Disheartening, Member Of Study Section Says

February 20, 1998

Drug Development Gets Extra $500,000

November 18, 1977